Colorectal Cancer Market was worth $4.14 billion in 2016 and estimated to be growing at a CAGR of 3.40%

Asia-Pacific Colorectal Cancer Market was worth $4.14 billion in 2016 and estimated to be growing at a CAGR of 3.40%, to reach $4.89 billion by 2021. 

Though there has been substantial development in science and technology to combat cancer, it continues to threaten lives across the globe.

Colorectal cancer results due to unrestrained cell growth that occurs in the appendix, colon, and the rectum region. Colorectal cancer is identified with a biopsy, which then followed by medical imaging to know its extent. Depending on the stage and how much the cancer has expanded, a combination of radiation therapy, chemotherapy, and targeted therapy is recommended by most oncologists.

Browse market data tables and in-depth TOC of the Asia-Pacific Colorectal Cancer Market to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-colorectal-cancer-market-613/

The growth of the Asia-Pacific Colorectal Cancer market is mainly due to the rise in aging population, and increasing awareness towards colorectal Cancer. However, poor accessibility of proper care, volatile economies and lack of awareness in this part of the world are the key factors hindering the growth of the market in this region.

Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-colorectal-cancer-market-613/request-sample

The Asia-Pacific Colorectal Cancer market is segmented based on Diagnosis and Treatment. The market for Colorectal Cancer, on the basis of Diagnosis is segmented into Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy. On the basis of Treatment, the global Colorectal Cancer market is segmented into Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies.

Inquire before buying @ http://www.marketdataforecast.com/market-reports/asia-pacific-colorectal-cancer-market-613/inquire

The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. The Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to reasons such as rising aging population and increasing participation of several private & public establishments to organize awareness programs on colorectal Cancer. China is the largest market for Colorectal Cancer in this region followed by India. Indonesia, Vietnam, and Malaysia, are some of the significant players in this market.

Avail discount @ http://www.marketdataforecast.com/market-reports/asia-pacific-colorectal-cancer-market-613/request-discount

The major companies dominating the market in this region are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD.

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases